Showing results (3251-3260 of 13,860) with videos related to

Sort By:
Pageof 1,386
American Heart Journal|July 31, 2024
Burden of hospitalization during the first year following transcatheter and surgical aortic valve replacementJawad H Butt, Adelina Yafasova, David Thein, et al.
American Heart Journal|July 21, 2024
Prognostic impact of quantitative flow ratio (QFR)-consistent complete revascularization in patients with myocardial infarction and multivessel coronary artery diseaseAslihan Erbay, Lisa Penzel, Youssef S Abdelwahed, et al.
American Heart Journal|July 20, 2024
Predicted prosthesis-patient mismatch and long-term clinical outcomes after transcatheter aortic valve replacement: A SWEDEHEART studyEmma Ellfors, Michael Dismorr, Andreas Rück, et al.
American Heart Journal|July 27, 2024
Malignant left ventricular hypertrophy and risk of cognitive impairment in SPRINT MIND trialRichard Kazibwe, Muhammad Imtiaz Ahmad, Timothy M Hughes, et al.
American Heart Journal|July 1, 2024
Electronic physician notification to facilitate the recognition and management of severe aortic stenosis: Rationale, design, and methods of the randomized controlled DETECT AS trialRoukoz Abou-Karam, Varsha Tanguturi, Fangzhou Cheng, et al.
American Heart Journal|July 12, 2024
Race, hypertensive disorders of pregnancy and outcomes in peripartum cardiomyopathyVincenzo B Polsinelli, Agnes Koczo, Amber E Johnson, et al.
American Heart Journal|May 5, 2024
Obicetrapib on top of maximally tolerated lipid-modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYNStephen J Nicholls, Adam J Nelson, Marc Ditmarsch, et al.
American Heart Journal|May 3, 2024
Comparison of downsizing strategy (HANGZHOU Solution) and standard annulus sizing strategy in type 0 bicuspid aortic stenosis patients undergoing transcatheter aortic valve replacement: Rationale and design of a randomized clinical trialYuchao Guo, Xianbao Liu, Ranxi Li, et al.
American Heart Journal|June 7, 2024
Prediction of 30-day mortality after surgery for infective endocarditis using risk scores: Insights from a European multicenter comparative validation studyGiuseppe Gatti, Antonio Fiore, Maria Ismail, et al.
American Heart Journal|June 12, 2024
Temporal changes in the number of European and American guideline recommendations and underlying evidence base for the management of infective: An update of previous published dataLauge Østergaard, Sofie Truong, Jeppe Petersen, et al.
Pageof 1,386